BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11368544)

  • 1. The food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: a conformational analysis of its major DNA adduct and comparison with the 2-amino-3-methylimidazo[4,5-f]quinoline adduct.
    Gauvin J; Broyde S; Shapiro R
    Chem Res Toxicol; 2001 May; 14(5):476-82. PubMed ID: 11368544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of the major DNA adduct derived from the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline.
    Wu X; Shapiro R; Broyde S
    Chem Res Toxicol; 1999 Oct; 12(10):895-905. PubMed ID: 10525264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine.
    Turesky RJ; Rossi SC; Welti DH; Lay JO; Kadlubar FF
    Chem Res Toxicol; 1992; 5(4):479-90. PubMed ID: 1391614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence modulates the conformation of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the recognition sequence of the NarI restriction enzyme.
    Wang F; Elmquist CE; Stover JS; Rizzo CJ; Stone MP
    Biochemistry; 2007 Jul; 46(29):8498-516. PubMed ID: 17602664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular mechanics and dynamics study of the minor adduct between DNA and the carcinogen 2-(acetylamino)fluorene (dG-N2-AAF).
    Grad R; Shapiro R; Hingerty BE; Broyde S
    Chem Res Toxicol; 1997 Oct; 10(10):1123-32. PubMed ID: 9348435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
    Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
    Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
    Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
    Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
    Pfau W; Brockstedt U; Söhren KD; Marquardt H
    Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-Displaced Intercalated Conformation of the 2-Amino-3-methylimidazo[4,5-f]quinoline N(2)-dG DNA Adduct Positioned at the Nonreiterated G(1) in the NarI Restriction Site.
    Stavros KM; Hawkins EK; Rizzo CJ; Stone MP
    Chem Res Toxicol; 2015 Jul; 28(7):1455-68. PubMed ID: 26083477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
    Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
    Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.
    Schut HA; Snyderwine EG
    Carcinogenesis; 1999 Mar; 20(3):353-68. PubMed ID: 10190547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx).
    Metry KJ; Neale JR; Doll MA; Howarth AL; States JC; McGregor WG; Pierce WM; Hein DW
    Mutat Res; 2010 Feb; 684(1-2):66-73. PubMed ID: 20004212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
    Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
    Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice.
    Turesky RJ; Bessette EE; Dunbar D; Liberman RG; Skipper PL
    Chem Res Toxicol; 2012 Feb; 25(2):410-21. PubMed ID: 22118226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
    Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
    Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
    Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
    Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational and DNA binding specificity of the carcinogen 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline.
    Solomon MS; Morgenthaler PM; Turesky RJ; Essigmann JM
    J Biol Chem; 1996 Aug; 271(31):18368-74. PubMed ID: 8702479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational differences of the C8-deoxyguanosine adduct of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) within the NarI recognition sequence.
    Elmquist CE; Wang F; Stover JS; Stone MP; Rizzo CJ
    Chem Res Toxicol; 2007 Mar; 20(3):445-54. PubMed ID: 17311423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.